MedTrace Logo

Testosterone Patch's Effects on the Cardiovascular System and Libido

NCT01208038 · Status: COMPLETED · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 22

Last updated 2020-01-02

Study results available
· View outcomes & findings →

Summary

The purpose of this study is to examine the effect of the testosterone patch, in addition to hormone replacement therapy (HRT), on blood vessel walls, insulin levels and sexual desire.

Conditions

  • Hypoactive Sexual Desire Disorder

Interventions

DRUG

Intrinsa Transdermal testosterone patch

300 microgram transdermal testosterone patch, applied twice weekly for 12 weeks

Sponsors & Collaborators

  • Royal Brompton & Harefield NHS Foundation Trust

    collaborator OTHER

  • Chelsea and Westminster NHS Foundation Trust

    collaborator OTHER

  • Imperial College Healthcare NHS Trust

    lead OTHER

Principal Investigators

  • Nick Panay, MBBS · Imperial College Healthcare NHS Trust

  • John C Stevenson, MBBS · Royal Brompton and Harefield NHS Foundation Trust

Study Design

Allocation
NA
Purpose
SUPPORTIVE_CARE
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
45 Years
Max Age
70 Years
Sex
FEMALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2011-03-31
Primary Completion
2012-02-29
Completion
2012-02-29

Countries

  • United Kingdom

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01208038 on ClinicalTrials.gov